Table 1.
RIT and CIT schedule.
Time | RIT | CIT | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Stage | Injection No. | Number of vials | Volume(ml) | Dose (TU) | Stage | Injection No. | Number of vials | Volume(ml) | Dose (TU) | |
D1 | Up-dosing phrase | 1 | 1 | 0.1 | 5 | Up-dosing phrase | 1 | 1 | 0.1 | 5 |
2 | 1 | 0.2 | 10 | |||||||
D2 | 3 | 1 | 0.4 | 20 | ||||||
4 | 1 | 0.8 | 40 | |||||||
D3 | 5 | 2 | 0.1 | 50 | ||||||
6 | 2 | 0.2 | 100 | |||||||
D4 | 7 | 2 | 0.4 | 200 | ||||||
8 | 2 | 0.8 | 400 | |||||||
D5 | 9 | 3 | 0.1 | 500 | ||||||
10 | 3 | 0.2 | 1000 | |||||||
D6 | 11 | 3 | 0.4 | 2000 | ||||||
12 | 3 | 0.6 | 3000 | |||||||
D7 | 13 | 3 | 1 | 5000 | ||||||
W2 | Maintenance phrase | 2 | 1 | 0.2 | 10 | |||||
W3 | 3 | 1 | 0.4 | 20 | ||||||
W4 | 4 | 1 | 0.8 | 40 | ||||||
W5 | 14 | 3 | 1 | 5000 | 5 | 2 | 0.1 | 50 | ||
W6 | 6 | 2 | 0.2 | 100 | ||||||
W7 | 7 | 2 | 0.4 | 200 | ||||||
W8 | 8 | 2 | 0.8 | 400 | ||||||
W9 | 9 | 3 | 0.1 | 500 | ||||||
W10 | 15 | 3 | 1 | 5000 | 10 | 3 | 0.2 | 1000 | ||
W11 | 11 | 3 | 0.4 | 2000 | ||||||
W12 | 12 | 3 | 0.6 | 3000 | ||||||
W13 | 13 | 3 | 0.8 | 4000 | ||||||
W14 | 14 | 3 | 1 | 5000 | ||||||
W15 | 16 | 3 | 1 | 5000 | Maintenance phrase | |||||
W16 | ||||||||||
W17 | ||||||||||
W18 | 15 | 3 | 1 | 5000 |
RIT, rush subcutaneous immunotherapy+1 dose of anti-IgE combination; CIT, conventional allergen immunotherapy; D, day; W, week.